Non-Inferiority Trial Workshop Needed For Nosocomial Pneumonia – Cmte.
Executive Summary
FDA's Anti-Infective Drugs Advisory Committee said a public workshop is needed to discuss non-inferiority trial design for antibiotics to treat nosocomial pneumonia (NP) and ventilator-associated pneumonia (VAP), similar to the workshop that was already held on community-acquired pneumonia